Controlling Cravings

A hormone made in the liver controls how much sugar mice eat, according to a study.

Written byJef Akst
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, DAVID PACEYA liver hormone called hepatokine fibroblast growth factor 21 (FGF21) influences cravings for sugar, according to a mouse study published last week (December 24) in Cell Metabolism. It is the first hormone found to regulate the consumption of a specific nutrient; other appetite-regulating hormones such as ghrelin and leptin—produced in the gut and in fat cells, respectively—act much more broadly, regulating overall caloric intake.

Specifically, Matthew Potthoff at the University of Iowa and his colleagues found that FGF21 suppresses a mouse’s consumption of simple sugars, but not of complex carbohydrates, proteins, or lipids. Mice lacking FGF21 drank much more sugary drink, while mice that overexpressed FGF21 or were dosed with the hormone consumed less sugar and noncaloric sweeteners. FGF21 appears to mediate such sweet-eating behavior via the hypothalamus, and the hormone increases following sugar consumption, suggesting a negative feedback loop regulating sugar intake.

“We conclude that the liver functions to regulate macronutrient-specific intake by producing an endocrine satiety signal that acts centrally to suppress the intake of ‘sweets,’” the authors wrote in their paper.

FGF21’s role in regulating sugar consumption was previously recognized after it was found to help ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies